Cash and cash equivalents (USD, thousands)

Accounts receivable, net (USD, thousands)

Inventory (USD, thousands)

Insurance receivables of litigation costs (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Total current assets (USD, thousands)

Property and equipment, net (USD, thousands)

Intangible assets, net (USD, thousands)

Operating lease right-of-use assets and other (USD, thousands)

Total assets (USD, thousands)

Current portion of long-term debt (USD, thousands)

Current portion of revenue interest obligation (USD, thousands)

Contingent liability for legal proceedings (USD, thousands)

Current operating lease liabilities (USD, thousands)

Total current liabilities (USD, thousands)

Long-term debt (USD, thousands)

Long-term revenue interest obligation (USD, thousands)

Warrant liability (USD, thousands)

Other long-term liabilities (USD, thousands)

Total liabilities (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated deficit (USD, thousands)

Total stockholders’ equity (deficit) (USD, thousands)

Total liabilities and stockholders' deficit (USD, thousands)

f77f671ccfd141afadd4437a610816e7e28d18f0b66ce3b5e46b0bbcb2886e98

Net sales (USD, thousands)

Cost of goods sold (USD, thousands)

Gross profit (USD, thousands)

Sales and marketing (USD, thousands)

General and administrative (USD, thousands)

Research and development (USD, thousands)

Litigation costs, net (USD, thousands)

Total operating expenses (USD, thousands)

Loss from operations (USD, thousands)

Interest expense (USD, thousands)

Other (income) expense, net (USD, thousands)

Loss before provision for income taxes (USD, thousands)

Income tax expense (USD, thousands)

Net loss (USD, thousands)

Net loss per share - basic and diluted (USD, per share)

Weighted average common shares outstanding - basic and diluted (Shares)

2291ff7d308786019ad2c404dbbc0f30b81965b9ad42dc01a784533648e34d06

Net cash used in operating activities (USD, thousands)

Net cash (used in) provided by investing activities (USD, thousands)

Net cash provided by (used in) financing activities (USD, thousands)

Net increase (decrease) in cash and cash equivalents (USD, thousands)

Cash paid for interest (USD, thousands)

Operating lease right-of-use asset extensions executed (USD, thousands)

Conversion of Common Warrants and Prefunded Warrants to common stock (USD, thousands)

Cash and cash equivalents, beginning of period (USD, thousands)

Cash and cash equivalents, end of period (USD, thousands)

Fair value of warrants issued (USD, thousands)

d43d28be21e873b1cca13d14ae92dbd56eba84a8b41978429ad5be71bf11ca6d

Device Protection

Women's Health

Cardiovascular

Orthobiologics

Core Products

Non-Core Products

Total Revenue

2c970a6e8badb4b2bf4a4971ce8af27a969d441de80242119788639bf3d1a2d4

Number of sales representatives and clinical specialists for EluPro and CanGaroo from Boston Scientific (representatives and clinical specialists)

Number of sales representatives for SimpliDerm from Tiger (representatives)

3cd9942cd423c34e412876250476a7081b5d7d69f7813baa2621facf23b6940b

Elutia Inc (ELUT)

Financials